 Vasopressins
"Vasopressins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.
| Descriptor ID |
D014667
|
| MeSH Number(s) |
D06.472.699.631.692.781 D12.644.400.900 D12.644.456.925 D12.644.548.691.692.781 D12.776.641.650.937
|
| Concept/Terms |
Vasopressins- Vasopressins
- beta-Hypophamine
- beta Hypophamine
- Antidiuretic Hormones
Pitressin- Pitressin
- Parke-Davis Brand of Vasopressin (USP)
- Monarch Brand of Vasopressin
- Vasopressin Monarch Brand
Vasopressin (USP)- Vasopressin (USP)
- American Regent Brand of Vasopressin
- Vasopressin
- American Pharmaceutical Brand of Vasopressin
|
Below are MeSH descriptors whose meaning is more general than "Vasopressins".
Below are MeSH descriptors whose meaning is more specific than "Vasopressins".
This graph shows the total number of publications written about "Vasopressins" by people in UAMS Profiles by year, and whether "Vasopressins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 0 | 1 | 1 | | 2019 | 4 | 0 | 4 | | 2018 | 1 | 2 | 3 | | 2017 | 3 | 0 | 3 | | 2015 | 2 | 0 | 2 | | 2014 | 0 | 2 | 2 | | 2009 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1997 | 0 | 2 | 2 | | 1996 | 1 | 0 | 1 | | 1992 | 0 | 1 | 1 | | 1991 | 1 | 0 | 1 | | 1989 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vasopressins" by people in Profiles over the past ten years.
-
Coleman RD, Chartan CA, Mourani PM. Intensive care management of right ventricular failure and pulmonary hypertension crises. Pediatr Pulmonol. 2021 03; 56(3):636-648.
-
Jansen LT, Suh H, Adams JD, Sprong CA, Seal AD, Scott DM, Butts CL, Melander O, Kirkland TW, Vanhaecke T, Dolci A, Lemetais G, Perrier ET, Kavouras SA. Osmotic stimulation of vasopressin acutely impairs glucose regulation: a counterbalanced, crossover trial. Am J Clin Nutr. 2019 12 01; 110(6):1344-1352.
-
Hammond DA, Sacha GL, Bissell BD, Musallam N, Altshuler D, Flannery AH, Lam SW, Bauer SR. Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta-Analysis. Pharmacotherapy. 2019 05; 39(5):544-552.
-
Menich BE, Miano TA, Patel GP, Hammond DA. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock. Ann Pharmacother. 2019 09; 53(9):877-885.
-
Hammond DA, Painter JT, Meena N. Incidence of Clinically Significant Hypotension Stratified by Vasopressin Duration. J Intensive Care Med. 2019 Jan; 34(1):77-78.
-
Frye RE. Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents. CNS Drugs. 2018 08; 32(8):713-734.
-
Srivastava R, Cornett LE, Chaturvedi CM. Impact of estrogen and photoperiod on arginine vasotocin and VT3 receptor expression in the shell gland of quail. Front Biosci (Schol Ed). 2018 06 01; 10(2):372-385.
-
Hammond DA, Ficek OA, Painter JT, McCain K, Cullen J, Brotherton AL, Kakkera K, Chopra D, Meena N. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock. Pharmacotherapy. 2018 05; 38(5):531-538.
-
Hammond DA, Cullen J, Painter JT, McCain K, Clem OA, Brotherton AL, Chopra D, Meena N. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock. J Intensive Care Med. 2019 Nov-Dec; 34(11-12):910-916.
-
Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock. J Intensive Care Med. 2019 Oct; 34(10):805-810.
-
Evans AE, Vana PG, LaPorte HM, Kennedy RH, Gamelli RL, Majetschak M. Cardiovascular Responsiveness to Vasopressin and a1-Adrenergic Receptor Agonists After Burn Injury. J Burn Care Res. 2017 Mar/Apr; 38(2):90-98.
-
Gandy J, Martinez H, Guelinckx I, Moreno LA, Bardosono S, Salas-Salvad? J, Kavouras SA. Relevance of Assessment Methods for Fluid Intake. Ann Nutr Metab. 2016; 68 Suppl 2:1-5.
-
Rios DR, Kaiser JR. Reply: To PMID 25641242. J Pediatr. 2015 Aug; 167(2):499.
-
Rios DR, Kaiser JR. Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study. J Pediatr. 2015 Apr; 166(4):850-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|